The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered, potentially paving the way for innovative treatments that align with the natural ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

In short, this study shows that poor sleep and poor diet can create the perfect storm for developing diabetes—not because you ...

Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease ...

Selling, general and administrative expenses were $2.6 billion in the first quarter, Merck noted, an increase of 3% compared with the first quarter of 2024. The increase was primarily due to higher ...